Alexion / AstraZeneca
Boston, Massachusetts
Alexion, now part of AstraZeneca's Rare Disease unit, specializes in treatments for rare and ultra-rare diseases. They are best known for Soliris and Ultomiris, complement inhibitors used to treat myasthenia gravis, PNH, and aHUS. These are among the most expensive drugs in the world, making insurance navigation especially critical.
Drugs
Hub Program — Alexion OneSource
- ✓Dedicated case manager for each patient
- ✓Insurance verification and prior authorization support
- ✓Copay assistance for commercially insured patients
- ✓Patient assistance program for uninsured/underinsured patients
- ✓Infusion coordination and ongoing therapy support
Patient Assistance
Copay Assistance
Alexion provides copay assistance programs for commercially insured patients on Soliris and Ultomiris, given the extremely high cost of these medications.
Patient Assistance Program (PAP)
Alexion Patient Assistance Program provides free medication to eligible uninsured patients. Given drug costs ($500,000+/year), this program is critical for uninsured patients.
Denied a Alexion / AstraZeneca Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.